Publications by authors named "Thomas C Hoock"

Claim this Profile
V
VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease.
Sudipta Mahajan, James K Hogan, Dina Shlyakhter, Luke Oh, Francesco G Salituro, Thomas C Hoock

J Pharmacol Exp Therยท May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis